Defined system to assess the in vitro induction of a psoriasis phenotype on normal keratinocytes by fibroblasts from psoriatic subjects

Journal of Cutaneous Medicine and Surgery

Volumn 2, Issue 1, 1997, Pages 20-25

  Krueger, Gerald G ^a   Jorgensen, Cynthia M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS HYPERPLASIA; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; MEDIATOR RELEASE; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; SKIN BIOPSY;

EID: 0031391590     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549700200105     Document Type: Article

References (25)

1. Krueger GG. A perspective of psoriasis as an aberration in skin modified to expression by the inflammatory/repair system. In: Norris DA, ed. Immune mechanisms in cutaneous disease. New York: Marcel Dekker, 1989:425-445.
2. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98:1878-1887.
3. Krueger JG, Wolfe JT, Nabeya-Tsukifuji R, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182:2067-2068.
4. Kupper TS. Mechanisms of cutaneous inflammation. Arch Dermatol 1989; 125:1406-1412.
5. Sporn MB, Roberts AB. Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 1986; 78:329-332.
6. Goustin AS, Leof EB, Shipley GD, et al. Growth factors and cancer. Cancer Res 1986; 46:1015-1029.
7. Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994; 220:10-18.
8. MacNeil S. What role does the extracellular matrix serve in skin grafting and wound healing? Burns 1994; 20:S67-S70.
9. Krueger GG, Jorgensen CM, Bradshaw BR, et al. An approach for and an assessment of interactive communication via cytokines of cellular components of skin. Proceedings of the International Symposium on Chemical Mediators in Skin Inflammation, Sendai, Japan, August 1988. Dermatologica 1989; 179:91-100.
10. Mackenzie I, Fusenig N. Regeneration of organized epithelial structure. J Invest Dermatol 1983; 81:189s-194s.
11. Worst P, Mackenzie I, Fusenig N. Reformation of organized epidermal structure by transplantation of suspensions and cultures of epidermal and dermal cells. Cell Tissue Res 1982; 225:65-77.
12. Gu XF, Raynaud F, Evain BD. Increased chemotactic and mitogenic response of psoriatic fibroblasts to platelet-derived growth factor. J Invest Dermatol 1988; 91:599-602.
13. Priestley G. Hyperactivity of fibroblasts cultured from psoriatic skin: II. Synthesis of macromolecules. Br J Dermatol 1983; 109:157-164.
14. Priestley G, Adams L. Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal. Br J Dermatol 1983; 109:149-156.
15. Priestley G, Adams L. Mitogenic effects of sera from normal and psoriatic subjects on human skin fibroblasts. Arch Dermatol Res 1985; 227:13-15.
16. Er RA, Charveron M, Bonafe JL. Increased superoxide anion production in dermal fibroblasts of psoriatic patients. Skin Pharmacol 1993; 6:253-258.
17. Saiag P, Coulomb B, Lebreton C, et al. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 1985; 230:669-672.
18. Konstantinova NV, Duong DMT, Remenyik E, et al. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J Invest Dermatol 1996; 107:615-621.
19. Rico M, Halprin K, Baker L, et al. Stimulated mitotic counts in the non-lesional skin of patients with psoriasis and controls. Br J Dermatol 1985; 113:185-188.
20. Fraki J, Briggaman R, Lazarus G. Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 1982; 215:685-687.
21. Krueger GG, Chambers DA, Shelby J. Involved and uninvolved skin from psoriatic subjects: are they equally diseased? J Clin Invest 1981; 68:1548-1557.
22. Harper R, Rispler J, Urbanek R. DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro. J Invest Dermatol 1978; 70:254-256.
23. Baker BS, Brent L, Valdimarsson H, et al. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol 1992; 126:105-110.
24. Nanney LB, Yates RA, King LE. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J Invest Dermatol 1992; 98:296-301.
25. Priestley GC, Lord R. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro. Br J Dermatol 1990; 123:467-472.